Clinical Research Directory
Browse clinical research sites, groups, and studies.
Using the Ending Self-Stigma Intervention to Reduce Internalized Stigma Among People Living With HIV Who Use Substances
Sponsor: Friends Research Institute, Inc.
Summary
The goal of this clinical trial is to test an intervention to reduce stigma among people living with HIV who use opioids and cocaine. The main question it aims to answer is: \- Does reducing internalized stigma about HIV and/or drug use lead to improved HIV care outcomes? After a year spent adapting an existing intervention to be applied specifically among people living with HIV who use substances, 70 participants will be randomized to receive either treatment-as-usual or the newly adapted intervention. The intervention itself will consist of five one-on-one sessions with a trained interventionist to discuss and work through the stigmas people commonly associate with HIV and/or substance use.
Official title: IRIS: Intervention to Reduce Internalized Stigma (IRIS) Among People Living With HIV Who Use Substances
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2023-02-17
Completion Date
2026-06-30
Last Updated
2025-07-20
Healthy Volunteers
No
Conditions
Interventions
Ending Self Stigma for Persons living with HIV and Use Substances
One-on-one intervention based on principles of cognitive behavioral therapy and social cognitive theory designed to reduce internalized stigma related to HIV and/or drug use.
Locations (2)
Friends Research Institute, Inc. Satellite Office
Newhall, California, United States
University of Maryland School of Medicine
Baltimore, Maryland, United States